Nektar Therapeutics Announces Multiple Presentations for Rezpegaldesleukin at EADV 2024

– New proteomic analyses show that rezpegaldesleukin increases the protein levels of immune-regulating pathways while reducing specific serum proteins known to be elevated in patients with atopic dermatitis – SAN FRANCISCO, Sept. 25, 2024 /PRNewswire/ — Nektar Therapeutics (Nasdaq: NKTR)…